GAURAV MANDAL

Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism BAY SHORE, NY NPI 1770103459

General Payments — all program years on this page

$1,227.71

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 32
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $819.84 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $792.0620
Education $27.781

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Lilly USA, LLC $170.024
Amgen Inc. $164.923
Corcept Therapeutics $148.647
Kyowa Kirin, Inc. $131.712
Alexion Pharmaceuticals, Inc. $117.061
Novo Nordisk AS $47.272
ABBVIE INC. $40.222

By program year

Program yearAmountRecords
2021 $17.301
2023 $390.5710
2024 $819.8421

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1104953060 ABBVIE INC. $20.41 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104953064 ABBVIE INC. $19.81 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108582139 Novo Nordisk Inc $22.34 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108583051 Novo Nordisk Inc $24.93 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110510112 Alexion Pharmaceuticals, Inc. $117.06 05/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111642336 Amgen Inc. $15.28 02/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111642338 Amgen Inc. $121.86 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117618758 Amgen Inc. $27.78 02/16/2024 Education Undisputed 01/23/2026 View at CMS
1117788229 Corcept Therapeutics $22.07 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117788247 Corcept Therapeutics $20.95 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117788255 Corcept Therapeutics $21.86 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117788319 Corcept Therapeutics $17.78 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117788475 Corcept Therapeutics $23.65 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117788489 Corcept Therapeutics $20.74 12/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117788501 Corcept Therapeutics $21.59 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127030353 Kyowa Kirin, Inc. $24.45 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127030355 Kyowa Kirin, Inc. $107.26 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134985728 Lilly USA, LLC $121.86 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134996332 Lilly USA, LLC $14.75 09/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135002092 Lilly USA, LLC $16.20 09/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135003253 Lilly USA, LLC $17.21 12/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.